<?xml version="1.0" encoding="UTF-8"?>
<p>Testing for RASs in clinical practice becomes important when the results would modify treatment management by impacting the duration of therapy and/or inclusion of ribavirin or result in selection of alternative therapy. However, at present the utility of RAS testing varies by both patient characteristics and DAA regimen. 
 <xref rid="T4" ref-type="table">Table 4</xref> depicts the regimen-specific recommendations for use of RAS testing in clinical practice.[
 <xref rid="ref61" ref-type="bibr">61</xref>]
</p>
